AI in Drug Development: Moving Beyond Early Use Cases
As new rules take hold, what does “good AI practice” look like in drug development?
False
Advertisement
Related Content
Development & Clinical
Future of Pharma
How Companion Diagnostics Can Support Targeted Drug Launches
September 29, 2026
5 min read
Coordinated development and practical testing pathways can help ensure eligible patients are identified from the point of approval
Future of Pharma
Regulation & Standards
What Do Scientists Want from AI?
September 14, 2026
5 min read
Scientists are already using AI in the lab – but many are doing so without the safeguards their employers may assume are in place
Future of Pharma
Future of Pharma
Business & Trends
What Will Drug Development Look Like in 2036?
September 3, 2026
7 min read
Members of The Medicine Maker’s 2026 Power List predict how AI, new modalities, integrated data, and shifting global markets will reshape the industry
Development & Clinical
Future of Pharma
Technology & Manufacturing
What Did ASCO 2026 Reveal About the Future of Oncology?
August 6, 2026
8 min read
Six drug development leaders discuss smarter immunotherapy combinations, the enduring potential of small molecules, emerging modalities, and how cancer treatment could evolve over the next two decades